← The Wire
EVMNNYSE
Evommune, Inc.
Pharmaceutical Preparations · DE · CIK 2044725
Evommune develops new therapies for chronic inflammatory diseases like CSU, AD, and UC
$714M
Market cap
$15.05
Last close
-40.2%
1D
-33.3%
5D
10.6M
Volume
Price · last 39 sessions-36.3%
May 4L $15.05 · H $25.18Jun 29
18
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 19, 2025: 4 insiders bought $70.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Hopfner Robert LorneDirector,TenPercentOwner | Buy | 1,000 | $17.35 | $17K |
| Nov 7, 2025 | Lsp 7 Cooperative UaTenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Nov 7, 2025 | Verduyn-Van Weegen Felice IsabelDirector,TenPercentOwner | Buy | 1,562,500 | $16.00 | $25.0M |
| Nov 7, 2025 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 1,157,096 | $16.00 | $18.5M |
| Nov 7, 2025 | Ra Capital Management, L.P.Director,TenPercentOwner | Buy | 92,904 | $16.00 | $1.5M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance